CLINICAL_TRIALS
trial_result
· 2013-02-28
Clinical Trial Update: Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma [Phase 2]
Summary
Phase 2 trial evaluating the combination of erlotinib and bevacizumab in patients with stage IV melanoma; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2013-02-28